Stay updated on Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a consolidated Locations section listing all trial sites by state. Removed the separate state-specific location headings (Arizona Locations, California Locations, etc.).SummaryDifference1%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page, indicating a minor site update. No changes to study content or layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedThe government funding/NIH operating status banner was removed from the page.SummaryDifference0.3%

- Check73 days agoChange DetectedNo additions or deletions were detected; only metadata updates (e.g., the 'Results First Posted' date) and minor formatting/UI refinements. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check94 days agoChange DetectedAdded a funding/operating status notice and a new version tag (v3.2.0); removed two specific cancer diagnoses and an older version tag (v3.1.0).SummaryDifference2%

- Check102 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content or data appears to be altered.SummaryDifference0.0%

Stay in the know with updates to Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.